Navigation Links
Endo Pharmaceuticals to Present at J.P. Morgan Annual Global High Yield & Leveraged Finance Conference
Date:2/17/2012

CHADDS FORD, Pa., Feb. 17, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Mark Gottlieb, vice president and treasurer, will present a corporate overview at the J.P. Morgan Annual Global High Yield & Leveraged Finance Conference on Wednesday, February 29, 2012 at 10:20 a.m. ET.  The conference will be held at the Loews Hotel in Miami Beach, FL.

A live webcast and audio archive of the presentation will be available on the company's website at http://www.endo.com/.  Click on Investor Relations, and then the link to the Event and Presentation.  Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo

Endo Pharmaceuticals Holdings is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments - branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals Holdings and its businesses American Medical Systems, HealthTronics and Qualitest Pharmaceuticals, please visit http://www.endo.com/.


'/>"/>
SOURCE Endo Pharmaceuticals Holdings
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
2. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
3. Omthera Pharmaceuticals, Inc. to Present at Leerink Swann 2012 Global Healthcare Conference and Citi 2012 Global Healthcare Conference
4. Jazz Pharmaceuticals to Announce 2011 Full Year and Fourth Quarter Financial Results on February 27, 2012
5. Vanda Pharmaceuticals Reports Fourth Quarter 2011 and Full Year 2011 Results
6. Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
7. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
8. Jubilant and Endo Pharmaceuticals Announce Successful Delivery of Early Milestones in Collaborative Discovery Program
9. Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models
10. Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain
11. Prismic Pharmaceuticals Acquires Scaristas Exclusive License to Amarins Omega-3 Patents for CNS Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
(Date:9/24/2017)... ... 24, 2017 , ... “The Gospel Truth Of The Bible: The Other Sheep”: the ceremonial laws ... Bible: The Other Sheep” is the creation of published author, Maurice Caines. Maurice Caines ... He has been a member of the Seventh-day Adventist Church for many years. ...
(Date:9/22/2017)... ... September 22, 2017 , ... MEDIA OPPORTUNITY: , Save Our Hospital - Albert ... why they are rallying against Mayo Clinic. Specifically, media can talk to steering committee ... (CEO) decision to close the Albert Lea hospital. , The rally aims to protect ...
(Date:9/22/2017)... Island, New York (PRWEB) , ... September 22, ... ... manufactures, delivers and assembles Passive House buildings, and Richard Pedranti Architect ... Prefabricated Passive House from the strategic partner’s Solsken Line of Model Homes ...
(Date:9/22/2017)... ... ... Happy Living’s mission - to improve the health and wellbeing of the ... delicious worlds of theatre and wines. , After watching Scott Barry perform on ... play into a book. The Greener The Grass ( https://www.happyliving.com/books/the-greener-the-grass ) was published on ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
Breaking Medicine News(10 mins):